Delivery Order SPE2DB20D3101-SPE2DB25FRPX9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Xtampza ER 13.5 mg capsules (100-count units) with a ceiling value of $2,302.80. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The ultimate completion date is July 23, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units) with a ceiling value of $8,590.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitively awarded contract with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the...
- The Defense Logistics Agency awarded a $1,344.17 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 16, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.69 to AmerisourceBergen Drug Corp for Xtampza ER 36 mg capsules (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pain management pharmaceutical supply for military and federal healthcare systems. The contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,085.35 for XTAMPZA ER 18 mg capsules (100-count units) on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The Defense Logistics Agency awarded a $2,319.51 delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.99 to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a long-acting opioid pain medication. The contract was competitively awarded with no set-aside designation, utilizing firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for 36mg Xtampza ER capsules valued at $6,176.76 on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for the federal military healthcare system. The vendor, headquartered in Conshohocken, Pennsylvania, serves as...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRPX9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Xtampza ER 18 mg capsules (100-count units) with a ceiling value of $5,707.86. This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made without a set-aside designation through competitive procurement, reflecting the vendor's demonstrated capability to meet federal pharmaceutical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical procurement needs across the Defense Health Agency and military healthcare systems. The company's comprehensive product portfolio under its DLA prime vendor contract encompasses brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains. This delivery order for Xtampza ER—an extended-release opioid analgesic—is consistent with the vendor's ongoing role in supplying pain management pharmaceuticals and other essential medical commodities to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/11/25 |